openPR Logo
Press release

Insights into the Duchenne Muscular Dystrophy Treatment Market - Therapies, Research, Patient Care, and Future Prospects

10-04-2023 11:43 AM CET | Health & Medicine

Press release from: Persistence Market Research

Duchenne Muscular Dystrophy Treatment Market

Duchenne Muscular Dystrophy Treatment Market

Market Overview:
The Duchenne Muscular Dystrophy (DMD) treatment market focuses on therapeutic interventions and pharmaceutical products for the management and treatment of Duchenne Muscular Dystrophy, a genetic disorder characterized by progressive muscle degeneration and weakness. The market aims to address the unmet medical needs of individuals affected by DMD, primarily children.

Market Size and Growth:
The global Duchenne Muscular Dystrophy treatment market was valued at approximately USD X billion in 2017. It is projected to grow at a compound annual growth rate (CAGR) of 48.3% from 2017 to 2026, reaching a market value of US$ 10,664.5 million by the end of the forecast period. The market growth is driven by advancements in therapeutic approaches, increased research and development activities, and the rising prevalence of DMD.

Seeking Deeper Insights into Competitor Analysis? Request a Sample of the Report Now! https://www.persistencemarketresearch.com/samples/12475

Market Segmentations:
By Treatment Type:
• Steroids (Corticosteroids)
• Exon Skipping Therapy
• Gene Therapy
• Cell Therapy
• Others

By Age Group:
• Pediatric (Children)
• Adult

By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Analysis:
The market for Duchenne Muscular Dystrophy treatment is global, with various regions contributing to market growth. The report provides analysis of the market in the following regions:
• North America (United States, Canada)
• Europe (United Kingdom, Germany, France, Italy, Spain)
• Asia Pacific (China, Japan, India, South Korea, Australia)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa

For Customized Insights on Segments, Regions, or Competitors, Request Personalized Purchase Options@ https://www.persistencemarketresearch.com/request-customization/12475

Key Players:
The Duchenne Muscular Dystrophy treatment market includes various pharmaceutical companies and research organizations working toward the development of effective treatments. Key players in the market include:
• Sarepta Therapeutics, Inc.
• PTC Therapeutics, Inc.
• Solid Biosciences Inc.
• Pfizer Inc.
• Wave Life Sciences Ltd.
• NS Pharma, Inc.
• Catabasis Pharmaceuticals, Inc.
• Summit Therapeutics plc
• FibroGen, Inc.
• Santhera Pharmaceuticals

Market Drivers:
• Increasing prevalence of Duchenne Muscular Dystrophy.
• Advancements in genetic and molecular therapies.
• Supportive regulatory environment and accelerated approval pathways.
• Growing focus on research and development in the field of rare diseases.

Challenges:
• High cost associated with DMD treatments.
• Limited accessibility to advanced therapies in developing regions.
• Long development timelines and regulatory complexities.

Trends:
• Development of personalized and precision medicine approaches for DMD treatment.
• Expansion of clinical trials and collaborations to accelerate therapeutic advancements.
• Integration of innovative technologies, such as gene editing and CRISPR, into DMD treatment approaches.

Unlock Exclusive Insights into Business Opportunities and Market Value - Get the Premium Insight Now! https://www.persistencemarketresearch.com/checkout/12475

Future Projections:
The Duchenne Muscular Dystrophy treatment market is expected to witness significant growth in the coming years. The development and commercialization of advanced therapies, such as gene therapy and exon skipping therapy, hold promise for improved management and outcomes for individuals with DMD. Additionally, increasing awareness, advocacy efforts, and collaborative initiatives are likely to drive the market's growth and lead to the discovery of new treatment options.

Explore the Latest Trend: Dive into the Exclusive "PMR" Article -
• Temporal Implants Market Opportunities - https://www.persistencemarketresearch.com/market-research/temporal-implants-market.asp

• Microneedle Patches Market Segments - https://www.persistencemarketresearch.com/market-research/microneedle-patches-market.asp

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights into the Duchenne Muscular Dystrophy Treatment Market - Therapies, Research, Patient Care, and Future Prospects here

News-ID: 3234422 • Views:

More Releases from Persistence Market Research

North America Household Washer and Dryer Market Set to Reach US$ 22.2 Bn by 2032, PMR Reports
North America Household Washer and Dryer Market Set to Reach US$ 22.2 Bn by 2032 …
The North America household washer and dryer market is poised for steady growth, supported by rising demand for smart home appliances, changing lifestyle patterns, and technological enhancements in laundry equipment. The market is projected to reach US$ 17.3 billion in 2025, and with a CAGR of 3.5% from 2025 to 2032, it is expected to climb to US$ 22.2 billion by 2032. ➤ Download Your Free Sample & Explore Key Insights:
Indoor Plants Market to Grow at 5.4% CAGR Through 2032 as Demand for Green Interiors Surges
Indoor Plants Market to Grow at 5.4% CAGR Through 2032 as Demand for Green Inter …
The global indoor plants market is poised for sustained expansion over the next several years. According to Persistence Market Research, the market is projected to grow from US$ 22.6 billion in 2025 to US$ 32.7 billion by 2032, reflecting a CAGR of 5.4% during the forecast period. This upward trajectory underscores the increasing consumer shift toward wellness-driven living, biophilic interiors, and nature-connected home environments. ➤ Download Your Free Sample & Explore
UV Disinfection Equipment Market Poised for Strong 16.3% CAGR Growth Through 2032
UV Disinfection Equipment Market Poised for Strong 16.3% CAGR Growth Through 203 …
The global UV disinfection equipment market is poised for remarkable expansion over the next decade. Industry estimates indicate that the market will be valued at US$ 17.0 billion in 2025 and is projected to surge to US$ 48.9 billion by 2032, registering a powerful CAGR of 16.3% between 2025 and 2032. This accelerated growth reflects heightened global focus on safety, hygiene, water quality, and chemical-free disinfection methods across both residential
Surfing Apparel and Accessories Market Booms at 5.5% CAGR Through 2031, Reports PMR
Surfing Apparel and Accessories Market Booms at 5.5% CAGR Through 2031, Reports …
The global surfing apparel and accessories market is set for steady expansion over the next several years. According to industry estimates, the market is anticipated to rise from US$ 9.5 billion in 2024 to US$ 14.1 billion by 2031, reflecting a healthy CAGR of 5.5% during the forecast period. This upward trajectory highlights the increasing global appeal of surfing as both a sport and a lifestyle. ➤ Download Your Free Sample

All 5 Releases


More Releases for Duchenne

Duchenne Muscular Dystrophy: Core Growth Enabler in the Rising Prevalence Of Chr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Duchenne Muscular Dystrophy Industry Market Size Be by 2025? The market size for Duchenne Muscular Dystrophy has shown significant expansion recently, burgeoning from $1.16 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The impressive growth in the
Emerging Trends Influencing The Growth Of The Duchenne Muscular Dystrophy (DMD) …
The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Expected to Be by 2034? In recent times, the market size for Duchenne Muscular Dystrophy (DMD) therapeutics has seen a significant
Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market in 2025: Bit B …
How Big Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Expected to Be, and What Will Its Growth Rate Be? The Duchenne muscular dystrophy (DMD) therapeutics market will grow from $11.95 billion in 2024 to $16.45 billion in 2025, at a CAGR of 37.6%. The growth is attributed to the increasing prevalence of Duchenne muscular dystrophy, rising awareness of treatment options, healthcare spending, and government initiatives. The Duchenne muscular dystrophy (DMD) therapeutics
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Duchenne Muscular Dystrophy Treatmcent Market
Global Duchenne Muscular Dystrophy Treatmcent Market Set for Robust Growth During Forecast Period The global Duchenne Muscular Dystrophy Treatment Market is poised to witness significant growth at a high Compound Annual Growth Rate (CAGR) during the forecast period of 2023 to 2030. Duchenne muscular dystrophy (DMD) stands as a genetic disorder marked by progressive muscle degeneration and weakness, with therapeutics aimed at addressing the absence of dystrophin, a crucial protein in
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market